UNC Childhood, Adolescent, and Young Adult Cancer Cohort

Part of paid clinical trials in Chapel Hill, North Carolina.

Sponsor
UNC Lineberger Comprehensive Cancer Center
Study ID
NCT05096923
Status
Recruiting
Apply to this trial

Conditions

  • Cancer
  • Cancer Metastatic
  • Pediatric Cancer
  • Survivorship

Eligibility Criteria

Sex
ALL
Age
1 Year - 39 Years
Healthy Volunteers
Not accepted

Study Details

Purpose: This study aims to create a registry of childhood, adolescent, and young adult patients with cancer (\<40 years-old at cancer diagnosis), entitled the 'UNC Childhood, Adolescent, and Young Adult Cancer Cohort' (UNC-CAYACC). This resource will serve to support cancer outcomes research among pediatric and young adult cancer patients with a primary focus on enrolling patients treated as adolescents or young adults (AYAs, 15-39 years). Procedures: As appropriate for age, participants will complete physical and cognitive functional assessments; questionnaires to assess health-related quality of life and other patient-reported outcomes; will undergo body composition and anthropometric measurements; and will be asked to provide biospecimens for biobanking. Assessments will be collected (as possible) at diagnosis, during active treatment, following treatment completion, and annually in survivorship to assess outcomes throughout the treatment and survivorship trajectory. Sociodemographic and clinical information such as cancer treatment modalities and cumulative doses will be collected by medical record abstraction. Participants will be eligible to enroll at any time from diagnosis through survivorship. This registry will provide data to better understand the manifestations of accelerated aging and key contributing factors among children, adolescents, and young adults with cancer.

Key Dates

Start date
Dec 17, 2021
Status verified
May 2026
Primary completion
Jan 31, 2031
Completion
Dec 31, 2031

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: UNC-CAYACC
    Children, adolescents, and young adults diagnosed with cancer before the age of 40 enrolled at any point during the diagnosis-treatment-survivorship continuum.

Primary Outcome Measure

Registry development [ Time Frame: Five years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of North Carolina at Chapel HillChapel HillNorth Carolina27599
Andrew Smitherman, MD
[email protected]
919-966-1178
Lauren Lux, MSW
[email protected]
984-974-8686

Find similar trials in Chapel Hill, NC

By research site
University of North Carolina at Chapel Hill· Chapel Hill, NC

Related Studies